Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. [electronic resource]
Producer: 20190924Description: 405-413 p. digitalISSN:- 2040-2058
- Adenine -- analogs & derivatives
- Adult
- Anti-Retroviral Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Coinfection
- DNA, Viral -- antagonists & inhibitors
- Drug Resistance, Viral -- drug effects
- Drug Utilization -- statistics & numerical data
- Europe
- Female
- Guanine -- analogs & derivatives
- HIV -- drug effects
- HIV Infections -- drug therapy
- Hepatitis B Surface Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Organophosphonates -- therapeutic use
- Polyethylene Glycols -- therapeutic use
- Practice Guidelines as Topic
- Prospective Studies
- Recombinant Proteins -- therapeutic use
- Tenofovir -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.